Biomedical Sciences Department, School of Pharmacy, Lebanese International, University, Beirut, Lebanon.
INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon.
Front Public Health. 2023 Apr 13;11:1156840. doi: 10.3389/fpubh.2023.1156840. eCollection 2023.
The COVID-19 pandemic has induced a global mental health crisis with variable consequences. This study aimed to assess the psychological impact of COVID-19 regarding anxiety, insomnia, depression, and response to trauma on pharmacists in Lebanon during COVID-19, and to identify factors contributing to psychological distress.
This was a cross-sectional study among pharmacists that involved the use of the 7-item Generalized Anxiety Disorder (GAD-7), 7-item Insomnia Severity Index (ISI), Patient Health Questionnaire 9-item depression module (PHQ-9), and Impact of Event Scale revised (IES-R) subscales. Descriptive statistical analyses were performed to determine the study distribution. The associations between the scores and the participants' characteristics were assessed using the Chi-square test. Four binary logistic regression models were used to evaluate the association between the scores and the potential confounders, followed by four multivariable logistic regressions. An alpha of 0.05 was used to determine statistical significance.
Participants comprised 311 pharmacists from all Lebanese districts, of whom 251 (80.7%) were females and 181 (58.2%) aged between 26 and 35 years. The majority of the participants were community pharmacists ( = 178, 57.2%). A considerable proportion of participants had symptoms of anxiety ( = 128, 41.2%), insomnia ( = 64, 20.6%), depression ( = 157, 50.5%), and subjective stress ( = 227, 78.8%). Higher anxiety (aOR: 1.73, 95% CI: 1.08; 2.78, -value: 0.02), higher depression (aOR: 3.06, 95% CI: 1.73; 5.39, p-value: 0.001), and higher stress (aOR: 1.86, 95 percent CI: 1.11; 3.14, p-value: 0.02) scores were significantly associated with pharmacists who reported that their work involves contact with infected/suspected COVID-19 patients. Interestingly, pharmacists who expressed concern about contracting COVID-19 infection had significantly higher anxiety (aOR: 2.35, 95% CI: 1.40; 3.94, -value: 0.001) and higher depression scores (aOR: 2.64, 95% CI: 1.49; 4.67, p-value: 0.001) respectively.
The preliminary results from pharmacists in Lebanon reflect increase in stress, burden, and frustration felt by pharmacists, creating a negative impact on their mental health and well-being during the global pandemic. As frontline healthcare workers, the role of pharmacists in the community should not be overlooked, and their mental health should be well investigated.
COVID-19 大流行引发了全球心理健康危机,其后果各不相同。本研究旨在评估 COVID-19 对黎巴嫩药剂师的焦虑、失眠、抑郁和创伤反应的心理影响,并确定导致心理困扰的因素。
这是一项针对药剂师的横断面研究,使用了 7 项广泛性焦虑障碍(GAD-7)、7 项失眠严重程度指数(ISI)、患者健康问卷 9 项抑郁模块(PHQ-9)和修订后的事件影响量表(IES-R)子量表。采用描述性统计分析确定研究分布。使用卡方检验评估评分与参与者特征之间的关联。使用四个二元逻辑回归模型评估评分与潜在混杂因素之间的关联,然后进行四个多变量逻辑回归。使用 0.05 的 alpha 值来确定统计学意义。
参与者包括来自黎巴嫩所有地区的 311 名药剂师,其中 251 名(80.7%)为女性,181 名(58.2%)年龄在 26 至 35 岁之间。大多数参与者是社区药剂师(=178,57.2%)。相当一部分参与者有焦虑症状(=128,41.2%)、失眠(=64,20.6%)、抑郁(=157,50.5%)和主观压力(=227,78.8%)。较高的焦虑(优势比:1.73,95%置信区间:1.08;2.78,-值:0.02)、较高的抑郁(优势比:3.06,95%置信区间:1.73;5.39,p 值:0.001)和较高的压力(优势比:1.86,95%置信区间:1.11;3.14,p 值:0.02)得分与报告工作涉及接触感染/疑似 COVID-19 患者的药剂师显著相关。有趣的是,对感染 COVID-19 表示担忧的药剂师的焦虑(优势比:2.35,95%置信区间:1.40;3.94,-值:0.001)和抑郁评分(优势比:2.64,95%置信区间:1.49;4.67,p 值:0.001)显著更高。
来自黎巴嫩药剂师的初步结果反映了药剂师在全球大流行期间感到的压力、负担和挫折感增加,对他们的心理健康和幸福感产生了负面影响。作为一线医疗保健工作者,不应忽视药剂师在社区中的作用,应充分调查他们的心理健康状况。